nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP3A4—Budesonide—ulcerative colitis	0.0854	0.125	CbGbCtD
Rimonabant—CYP1A2—Nicotine—ulcerative colitis	0.071	0.104	CbGbCtD
Rimonabant—CYP2C9—Nicotine—ulcerative colitis	0.0639	0.0935	CbGbCtD
Rimonabant—CYP2D6—Nicotine—ulcerative colitis	0.0585	0.0855	CbGbCtD
Rimonabant—CYP2C9—Cholecalciferol—ulcerative colitis	0.0573	0.0839	CbGbCtD
Rimonabant—CYP2D6—Cholecalciferol—ulcerative colitis	0.0524	0.0767	CbGbCtD
Rimonabant—CYP3A4—Methylprednisolone—ulcerative colitis	0.0382	0.0558	CbGbCtD
Rimonabant—CYP3A4—Nicotine—ulcerative colitis	0.0372	0.0544	CbGbCtD
Rimonabant—CYP3A4—Cholecalciferol—ulcerative colitis	0.0333	0.0488	CbGbCtD
Rimonabant—CYP3A4—Triamcinolone—ulcerative colitis	0.0289	0.0423	CbGbCtD
Rimonabant—CYP2C9—Dexamethasone—ulcerative colitis	0.0248	0.0363	CbGbCtD
Rimonabant—CYP3A4—Betamethasone—ulcerative colitis	0.0248	0.0363	CbGbCtD
Rimonabant—CYP3A4—Prednisolone—ulcerative colitis	0.0245	0.0358	CbGbCtD
Rimonabant—CYP3A4—Hydrocortisone—ulcerative colitis	0.0232	0.0339	CbGbCtD
Rimonabant—CYP3A4—Prednisone—ulcerative colitis	0.0231	0.0338	CbGbCtD
Rimonabant—CYP2D6—Dexamethasone—ulcerative colitis	0.0227	0.0332	CbGbCtD
Rimonabant—CYP3A4—Dexamethasone—ulcerative colitis	0.0144	0.0211	CbGbCtD
Rimonabant—CNR2—Small Ligand GPCRs—PTGER4—ulcerative colitis	0.00683	0.0717	CbGpPWpGaD
Rimonabant—CNR1—Small Ligand GPCRs—PTGER4—ulcerative colitis	0.00536	0.0563	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00365	0.0383	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.00287	0.0301	CbGpPWpGaD
Rimonabant—CNR1—N-cadherin signaling events—CALM3—ulcerative colitis	0.00285	0.0299	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—CXCR1—ulcerative colitis	0.00236	0.0248	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—CXCR2—ulcerative colitis	0.00185	0.0194	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00141	0.0148	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00131	0.0137	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00124	0.013	CbGpPWpGaD
Rimonabant—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.0012	0.0126	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—ADRB2—ulcerative colitis	0.00116	0.0122	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00112	0.0118	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCR1—ulcerative colitis	0.00111	0.0116	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.0011	0.0116	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00104	0.0109	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.00103	0.0108	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00102	0.0108	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000984	0.0103	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CCL20—ulcerative colitis	0.000972	0.0102	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000963	0.0101	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00088	0.00924	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000877	0.00921	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.000866	0.00909	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCR1—ulcerative colitis	0.000854	0.00896	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000848	0.0089	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000825	0.00866	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CCR6—ulcerative colitis	0.000814	0.00855	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000804	0.00844	CbGpPWpGaD
Rimonabant—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000787	0.00826	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000772	0.00811	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000756	0.00793	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL20—ulcerative colitis	0.00075	0.00787	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000726	0.00763	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000689	0.00723	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00067	0.00703	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCR2—ulcerative colitis	0.000668	0.00702	CbGpPWpGaD
Rimonabant—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000668	0.00302	CcSEcCtD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000665	0.00698	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000665	0.00698	CbGpPWpGaD
Rimonabant—Dry mouth—Budesonide—ulcerative colitis	0.000664	0.00301	CcSEcCtD
Rimonabant—Mental disorder—Mesalazine—ulcerative colitis	0.000653	0.00295	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000647	0.0068	CbGpPWpGaD
Rimonabant—Diarrhoea—Nicotine—ulcerative colitis	0.000647	0.00293	CcSEcCtD
Rimonabant—Infection—Budesonide—ulcerative colitis	0.000647	0.00293	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000642	0.00675	CbGpPWpGaD
Rimonabant—Psychotic disorder—Dexamethasone—ulcerative colitis	0.000639	0.00289	CcSEcCtD
Rimonabant—Psychotic disorder—Betamethasone—ulcerative colitis	0.000639	0.00289	CcSEcCtD
Rimonabant—Nervous system disorder—Budesonide—ulcerative colitis	0.000639	0.00289	CcSEcCtD
Rimonabant—Tension—Mesalazine—ulcerative colitis	0.000637	0.00288	CcSEcCtD
Rimonabant—Skin disorder—Budesonide—ulcerative colitis	0.000633	0.00286	CcSEcCtD
Rimonabant—Nervousness—Mesalazine—ulcerative colitis	0.00063	0.00285	CcSEcCtD
Rimonabant—Hyperhidrosis—Budesonide—ulcerative colitis	0.00063	0.00285	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCR6—ulcerative colitis	0.000628	0.0066	CbGpPWpGaD
Rimonabant—Dizziness—Nicotine—ulcerative colitis	0.000625	0.00283	CcSEcCtD
Rimonabant—Irritability—Betamethasone—ulcerative colitis	0.000625	0.00283	CcSEcCtD
Rimonabant—Irritability—Dexamethasone—ulcerative colitis	0.000625	0.00283	CcSEcCtD
Rimonabant—Muscle spasms—Mesalazine—ulcerative colitis	0.000624	0.00282	CcSEcCtD
Rimonabant—Influenza—Triamcinolone—ulcerative colitis	0.000624	0.00282	CcSEcCtD
Rimonabant—Anorexia—Budesonide—ulcerative colitis	0.000621	0.00281	CcSEcCtD
Rimonabant—Vomiting—Mercaptopurine—ulcerative colitis	0.00062	0.00281	CcSEcCtD
Rimonabant—Mood swings—Dexamethasone—ulcerative colitis	0.00062	0.00281	CcSEcCtD
Rimonabant—Mood swings—Betamethasone—ulcerative colitis	0.00062	0.00281	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000616	0.00278	CcSEcCtD
Rimonabant—Rash—Mercaptopurine—ulcerative colitis	0.000615	0.00278	CcSEcCtD
Rimonabant—Dermatitis—Mercaptopurine—ulcerative colitis	0.000615	0.00278	CcSEcCtD
Rimonabant—Tremor—Mesalazine—ulcerative colitis	0.000608	0.00275	CcSEcCtD
Rimonabant—Amnesia—Prednisone—ulcerative colitis	0.000607	0.00275	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000602	0.00273	CcSEcCtD
Rimonabant—Vomiting—Nicotine—ulcerative colitis	0.000601	0.00272	CcSEcCtD
Rimonabant—Rash—Nicotine—ulcerative colitis	0.000596	0.0027	CcSEcCtD
Rimonabant—Dermatitis—Nicotine—ulcerative colitis	0.000596	0.00269	CcSEcCtD
Rimonabant—Headache—Nicotine—ulcerative colitis	0.000592	0.00268	CcSEcCtD
Rimonabant—Infestation—Hydrocortisone—ulcerative colitis	0.000591	0.00267	CcSEcCtD
Rimonabant—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000591	0.00267	CcSEcCtD
Rimonabant—Insomnia—Budesonide—ulcerative colitis	0.000589	0.00266	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCL20—ulcerative colitis	0.000588	0.00618	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000588	0.00617	CbGpPWpGaD
Rimonabant—Paraesthesia—Budesonide—ulcerative colitis	0.000585	0.00265	CcSEcCtD
Rimonabant—Lethargy—Prednisone—ulcerative colitis	0.000582	0.00263	CcSEcCtD
Rimonabant—Nausea—Mercaptopurine—ulcerative colitis	0.00058	0.00262	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.00058	0.00262	CcSEcCtD
Rimonabant—Infection—Azathioprine—ulcerative colitis	0.000578	0.00261	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00057	0.00598	CbGpPWpGaD
Rimonabant—Decreased appetite—Budesonide—ulcerative colitis	0.000566	0.00256	CcSEcCtD
Rimonabant—Skin disorder—Azathioprine—ulcerative colitis	0.000565	0.00256	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000562	0.00254	CcSEcCtD
Rimonabant—Nausea—Nicotine—ulcerative colitis	0.000562	0.00254	CcSEcCtD
Rimonabant—Fatigue—Budesonide—ulcerative colitis	0.000561	0.00254	CcSEcCtD
Rimonabant—Psychotic disorder—Prednisone—ulcerative colitis	0.000557	0.00252	CcSEcCtD
Rimonabant—Infestation—Methylprednisolone—ulcerative colitis	0.000555	0.00251	CcSEcCtD
Rimonabant—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000555	0.00251	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—PTGER4—ulcerative colitis	0.000553	0.00581	CbGpPWpGaD
Rimonabant—Anxiety—Mesalazine—ulcerative colitis	0.000551	0.00249	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00055	0.00578	CbGpPWpGaD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000549	0.00248	CcSEcCtD
Rimonabant—Irritability—Prednisone—ulcerative colitis	0.000544	0.00246	CcSEcCtD
Rimonabant—Dry mouth—Mesalazine—ulcerative colitis	0.00054	0.00244	CcSEcCtD
Rimonabant—Mood swings—Prednisone—ulcerative colitis	0.00054	0.00244	CcSEcCtD
Rimonabant—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000533	0.00241	CcSEcCtD
Rimonabant—Hallucination—Hydrocortisone—ulcerative colitis	0.000527	0.00239	CcSEcCtD
Rimonabant—Infection—Mesalazine—ulcerative colitis	0.000526	0.00238	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000524	0.0055	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000522	0.00548	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000521	0.00236	CcSEcCtD
Rimonabant—Nervous system disorder—Mesalazine—ulcerative colitis	0.000519	0.00235	CcSEcCtD
Rimonabant—Abdominal pain—Budesonide—ulcerative colitis	0.000515	0.00233	CcSEcCtD
Rimonabant—Skin disorder—Mesalazine—ulcerative colitis	0.000514	0.00233	CcSEcCtD
Rimonabant—Hyperhidrosis—Mesalazine—ulcerative colitis	0.000512	0.00232	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—GHRL—ulcerative colitis	0.000506	0.00532	CbGpPWpGaD
Rimonabant—Anorexia—Mesalazine—ulcerative colitis	0.000505	0.00228	CcSEcCtD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000504	0.00529	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000502	0.00227	CcSEcCtD
Rimonabant—Hallucination—Methylprednisolone—ulcerative colitis	0.000496	0.00224	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCR6—ulcerative colitis	0.000493	0.00518	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000489	0.00221	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000483	0.00507	CbGpPWpGaD
Rimonabant—Insomnia—Mesalazine—ulcerative colitis	0.000479	0.00217	CcSEcCtD
Rimonabant—Paraesthesia—Mesalazine—ulcerative colitis	0.000476	0.00215	CcSEcCtD
Rimonabant—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000475	0.00215	CcSEcCtD
Rimonabant—Asthenia—Budesonide—ulcerative colitis	0.000467	0.00211	CcSEcCtD
Rimonabant—Mental disorder—Hydrocortisone—ulcerative colitis	0.000464	0.0021	CcSEcCtD
Rimonabant—Malnutrition—Hydrocortisone—ulcerative colitis	0.000461	0.00209	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000461	0.00484	CbGpPWpGaD
Rimonabant—Pruritus—Budesonide—ulcerative colitis	0.000461	0.00208	CcSEcCtD
Rimonabant—Decreased appetite—Mesalazine—ulcerative colitis	0.00046	0.00208	CcSEcCtD
Rimonabant—Abdominal pain—Azathioprine—ulcerative colitis	0.00046	0.00208	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000457	0.00207	CcSEcCtD
Rimonabant—Fatigue—Mesalazine—ulcerative colitis	0.000457	0.00207	CcSEcCtD
Rimonabant—Angiopathy—Methylprednisolone—ulcerative colitis	0.000452	0.00204	CcSEcCtD
Rimonabant—Hallucination—Betamethasone—ulcerative colitis	0.000451	0.00204	CcSEcCtD
Rimonabant—Hallucination—Dexamethasone—ulcerative colitis	0.000451	0.00204	CcSEcCtD
Rimonabant—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000449	0.00203	CcSEcCtD
Rimonabant—Diarrhoea—Budesonide—ulcerative colitis	0.000446	0.00202	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCR1—ulcerative colitis	0.000438	0.0046	CbGpPWpGaD
Rimonabant—Depression—Prednisone—ulcerative colitis	0.000438	0.00198	CcSEcCtD
Rimonabant—Mental disorder—Methylprednisolone—ulcerative colitis	0.000436	0.00197	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000434	0.00456	CbGpPWpGaD
Rimonabant—Malnutrition—Methylprednisolone—ulcerative colitis	0.000434	0.00196	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000433	0.00196	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000432	0.00453	CbGpPWpGaD
Rimonabant—Dizziness—Budesonide—ulcerative colitis	0.000431	0.00195	CcSEcCtD
Rimonabant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000431	0.00452	CbGpPWpGaD
Rimonabant—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00043	0.00451	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—JAK2—ulcerative colitis	0.000425	0.00447	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CCL20—ulcerative colitis	0.000424	0.00445	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—ADRB2—ulcerative colitis	0.000419	0.0044	CbGpPWpGaD
Rimonabant—Abdominal pain—Mesalazine—ulcerative colitis	0.000419	0.00189	CcSEcCtD
Rimonabant—Vomiting—Budesonide—ulcerative colitis	0.000414	0.00187	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—RELA—ulcerative colitis	0.000412	0.00433	CbGpPWpGaD
Rimonabant—Angiopathy—Betamethasone—ulcerative colitis	0.000411	0.00186	CcSEcCtD
Rimonabant—Angiopathy—Dexamethasone—ulcerative colitis	0.000411	0.00186	CcSEcCtD
Rimonabant—Rash—Budesonide—ulcerative colitis	0.000411	0.00186	CcSEcCtD
Rimonabant—Dermatitis—Budesonide—ulcerative colitis	0.00041	0.00186	CcSEcCtD
Rimonabant—Convulsion—Prednisolone—ulcerative colitis	0.000409	0.00185	CcSEcCtD
Rimonabant—Headache—Budesonide—ulcerative colitis	0.000408	0.00185	CcSEcCtD
Rimonabant—Convulsion—Hydrocortisone—ulcerative colitis	0.0004	0.00181	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—GNA12—ulcerative colitis	0.000398	0.00418	CbGpPWpGaD
Rimonabant—Diarrhoea—Azathioprine—ulcerative colitis	0.000398	0.0018	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—GHRL—ulcerative colitis	0.000397	0.00417	CbGpPWpGaD
Rimonabant—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000394	0.00413	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000393	0.00413	CbGpPWpGaD
Rimonabant—Hallucination—Prednisone—ulcerative colitis	0.000392	0.00178	CcSEcCtD
Rimonabant—Anxiety—Hydrocortisone—ulcerative colitis	0.000392	0.00177	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00039	0.00177	CcSEcCtD
Rimonabant—Connective tissue disorder—Prednisone—ulcerative colitis	0.000388	0.00175	CcSEcCtD
Rimonabant—Nausea—Budesonide—ulcerative colitis	0.000387	0.00175	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCL20—ulcerative colitis	0.000385	0.00404	CbGpPWpGaD
Rimonabant—Dizziness—Azathioprine—ulcerative colitis	0.000385	0.00174	CcSEcCtD
Rimonabant—Asthenia—Mesalazine—ulcerative colitis	0.00038	0.00172	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000379	0.00398	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000378	0.00396	CbGpPWpGaD
Rimonabant—Convulsion—Triamcinolone—ulcerative colitis	0.000376	0.0017	CcSEcCtD
Rimonabant—Convulsion—Methylprednisolone—ulcerative colitis	0.000376	0.0017	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000375	0.00394	CbGpPWpGaD
Rimonabant—Pruritus—Mesalazine—ulcerative colitis	0.000375	0.0017	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000374	0.00393	CbGpPWpGaD
Rimonabant—Infection—Hydrocortisone—ulcerative colitis	0.000374	0.00169	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000373	0.00169	CcSEcCtD
Rimonabant—Vomiting—Azathioprine—ulcerative colitis	0.00037	0.00167	CcSEcCtD
Rimonabant—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000369	0.00167	CcSEcCtD
Rimonabant—Anxiety—Methylprednisolone—ulcerative colitis	0.000368	0.00166	CcSEcCtD
Rimonabant—Rash—Azathioprine—ulcerative colitis	0.000367	0.00166	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000367	0.00166	CcSEcCtD
Rimonabant—Dermatitis—Azathioprine—ulcerative colitis	0.000366	0.00166	CcSEcCtD
Rimonabant—Skin disorder—Hydrocortisone—ulcerative colitis	0.000366	0.00166	CcSEcCtD
Rimonabant—Headache—Azathioprine—ulcerative colitis	0.000364	0.00165	CcSEcCtD
Rimonabant—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000364	0.00165	CcSEcCtD
Rimonabant—Diarrhoea—Mesalazine—ulcerative colitis	0.000362	0.00164	CcSEcCtD
Rimonabant—Dry mouth—Triamcinolone—ulcerative colitis	0.000362	0.00164	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—GNA12—ulcerative colitis	0.000362	0.0038	CbGpPWpGaD
Rimonabant—Anorexia—Hydrocortisone—ulcerative colitis	0.000359	0.00162	CcSEcCtD
Rimonabant—Angiopathy—Prednisone—ulcerative colitis	0.000358	0.00162	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CCR6—ulcerative colitis	0.000355	0.00373	CbGpPWpGaD
Rimonabant—Infection—Triamcinolone—ulcerative colitis	0.000352	0.00159	CcSEcCtD
Rimonabant—Infection—Methylprednisolone—ulcerative colitis	0.000352	0.00159	CcSEcCtD
Rimonabant—Dizziness—Mesalazine—ulcerative colitis	0.00035	0.00158	CcSEcCtD
Rimonabant—Insomnia—Prednisolone—ulcerative colitis	0.000349	0.00158	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NFKB1—ulcerative colitis	0.000347	0.00365	CbGpPWpGaD
Rimonabant—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000347	0.00157	CcSEcCtD
Rimonabant—Paraesthesia—Prednisolone—ulcerative colitis	0.000346	0.00157	CcSEcCtD
Rimonabant—Mental disorder—Prednisone—ulcerative colitis	0.000346	0.00156	CcSEcCtD
Rimonabant—Nausea—Azathioprine—ulcerative colitis	0.000345	0.00156	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000344	0.00361	CbGpPWpGaD
Rimonabant—Skin disorder—Methylprednisolone—ulcerative colitis	0.000344	0.00155	CcSEcCtD
Rimonabant—Malnutrition—Prednisone—ulcerative colitis	0.000343	0.00155	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCR2—ulcerative colitis	0.000343	0.0036	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000343	0.00155	CcSEcCtD
Rimonabant—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000342	0.00155	CcSEcCtD
Rimonabant—Convulsion—Betamethasone—ulcerative colitis	0.000342	0.00155	CcSEcCtD
Rimonabant—Convulsion—Dexamethasone—ulcerative colitis	0.000342	0.00155	CcSEcCtD
Rimonabant—Insomnia—Hydrocortisone—ulcerative colitis	0.000341	0.00154	CcSEcCtD
Rimonabant—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000338	0.00153	CcSEcCtD
Rimonabant—Vomiting—Mesalazine—ulcerative colitis	0.000337	0.00152	CcSEcCtD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000336	0.00353	CbGpPWpGaD
Rimonabant—Anxiety—Dexamethasone—ulcerative colitis	0.000335	0.00151	CcSEcCtD
Rimonabant—Anxiety—Betamethasone—ulcerative colitis	0.000335	0.00151	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000334	0.00351	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000334	0.00351	CbGpPWpGaD
Rimonabant—Rash—Mesalazine—ulcerative colitis	0.000334	0.00151	CcSEcCtD
Rimonabant—Dermatitis—Mesalazine—ulcerative colitis	0.000334	0.00151	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000332	0.00349	CbGpPWpGaD
Rimonabant—Headache—Mesalazine—ulcerative colitis	0.000332	0.0015	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000329	0.00345	CbGpPWpGaD
Rimonabant—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000327	0.00148	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000325	0.00147	CcSEcCtD
Rimonabant—Fatigue—Hydrocortisone—ulcerative colitis	0.000325	0.00147	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCR6—ulcerative colitis	0.000322	0.00338	CbGpPWpGaD
Rimonabant—Insomnia—Triamcinolone—ulcerative colitis	0.000321	0.00145	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00032	0.00336	CbGpPWpGaD
Rimonabant—Insomnia—Methylprednisolone—ulcerative colitis	0.00032	0.00145	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00032	0.00336	CbGpPWpGaD
Rimonabant—Infection—Dexamethasone—ulcerative colitis	0.00032	0.00145	CcSEcCtD
Rimonabant—Infection—Betamethasone—ulcerative colitis	0.00032	0.00145	CcSEcCtD
Rimonabant—Paraesthesia—Triamcinolone—ulcerative colitis	0.000318	0.00144	CcSEcCtD
Rimonabant—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000318	0.00144	CcSEcCtD
Rimonabant—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000316	0.00143	CcSEcCtD
Rimonabant—Nervous system disorder—Betamethasone—ulcerative colitis	0.000316	0.00143	CcSEcCtD
Rimonabant—Nausea—Mesalazine—ulcerative colitis	0.000315	0.00142	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—SEL1L—ulcerative colitis	0.000314	0.0033	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000313	0.00328	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000313	0.00328	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—STAT3—ulcerative colitis	0.000312	0.00328	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000311	0.00141	CcSEcCtD
Rimonabant—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000311	0.00141	CcSEcCtD
Rimonabant—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000308	0.00139	CcSEcCtD
Rimonabant—Anorexia—Betamethasone—ulcerative colitis	0.000307	0.00139	CcSEcCtD
Rimonabant—Anorexia—Dexamethasone—ulcerative colitis	0.000307	0.00139	CcSEcCtD
Rimonabant—Fatigue—Triamcinolone—ulcerative colitis	0.000306	0.00138	CcSEcCtD
Rimonabant—Fatigue—Methylprednisolone—ulcerative colitis	0.000305	0.00138	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL20—ulcerative colitis	0.000302	0.00317	CbGpPWpGaD
Rimonabant—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000298	0.00135	CcSEcCtD
Rimonabant—Convulsion—Prednisone—ulcerative colitis	0.000298	0.00135	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000296	0.00311	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	0.000295	0.0031	CbGpPWpGaD
Rimonabant—Anxiety—Prednisone—ulcerative colitis	0.000291	0.00132	CcSEcCtD
Rimonabant—Insomnia—Dexamethasone—ulcerative colitis	0.000291	0.00132	CcSEcCtD
Rimonabant—Insomnia—Betamethasone—ulcerative colitis	0.000291	0.00132	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00029	0.00131	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000289	0.00131	CcSEcCtD
Rimonabant—Paraesthesia—Betamethasone—ulcerative colitis	0.000289	0.00131	CcSEcCtD
Rimonabant—Paraesthesia—Dexamethasone—ulcerative colitis	0.000289	0.00131	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—GHRL—ulcerative colitis	0.000286	0.003	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000284	0.00298	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PTGER4—ulcerative colitis	0.000284	0.00298	CbGpPWpGaD
Rimonabant—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00028	0.00127	CcSEcCtD
Rimonabant—Decreased appetite—Betamethasone—ulcerative colitis	0.00028	0.00127	CcSEcCtD
Rimonabant—Decreased appetite—Dexamethasone—ulcerative colitis	0.00028	0.00127	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000279	0.00292	CbGpPWpGaD
Rimonabant—Infection—Prednisone—ulcerative colitis	0.000278	0.00126	CcSEcCtD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000278	0.00292	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000278	0.00126	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000278	0.00126	CcSEcCtD
Rimonabant—Fatigue—Betamethasone—ulcerative colitis	0.000277	0.00126	CcSEcCtD
Rimonabant—Fatigue—Dexamethasone—ulcerative colitis	0.000277	0.00126	CcSEcCtD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000276	0.00289	CbGpPWpGaD
Rimonabant—Nervous system disorder—Prednisone—ulcerative colitis	0.000275	0.00124	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—ulcerative colitis	0.000272	0.00123	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisone—ulcerative colitis	0.000271	0.00123	CcSEcCtD
Rimonabant—Asthenia—Hydrocortisone—ulcerative colitis	0.00027	0.00122	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.000269	0.00282	CbGpPWpGaD
Rimonabant—Anorexia—Prednisone—ulcerative colitis	0.000267	0.00121	CcSEcCtD
Rimonabant—Pruritus—Hydrocortisone—ulcerative colitis	0.000266	0.00121	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000266	0.00279	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000263	0.00119	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000263	0.00119	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.000262	0.00275	CbGpPWpGaD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000261	0.00274	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—GHRL—ulcerative colitis	0.00026	0.00273	CbGpPWpGaD
Rimonabant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00026	0.00273	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCR1—ulcerative colitis	0.000259	0.00272	CbGpPWpGaD
Rimonabant—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000258	0.00117	CcSEcCtD
Rimonabant—Dizziness—Prednisolone—ulcerative colitis	0.000255	0.00115	CcSEcCtD
Rimonabant—Asthenia—Triamcinolone—ulcerative colitis	0.000254	0.00115	CcSEcCtD
Rimonabant—Abdominal pain—Betamethasone—ulcerative colitis	0.000254	0.00115	CcSEcCtD
Rimonabant—Abdominal pain—Dexamethasone—ulcerative colitis	0.000254	0.00115	CcSEcCtD
Rimonabant—Asthenia—Methylprednisolone—ulcerative colitis	0.000254	0.00115	CcSEcCtD
Rimonabant—Insomnia—Prednisone—ulcerative colitis	0.000253	0.00115	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCR6—ulcerative colitis	0.000253	0.00266	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CALM3—ulcerative colitis	0.000252	0.00264	CbGpPWpGaD
Rimonabant—Paraesthesia—Prednisone—ulcerative colitis	0.000252	0.00114	CcSEcCtD
Rimonabant—Pruritus—Triamcinolone—ulcerative colitis	0.000251	0.00114	CcSEcCtD
Rimonabant—Pruritus—Methylprednisolone—ulcerative colitis	0.00025	0.00113	CcSEcCtD
Rimonabant—Dizziness—Hydrocortisone—ulcerative colitis	0.000249	0.00113	CcSEcCtD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000247	0.0026	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000247	0.00259	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SEL1L—ulcerative colitis	0.000247	0.00259	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000245	0.00258	CbGpPWpGaD
Rimonabant—Decreased appetite—Prednisone—ulcerative colitis	0.000244	0.0011	CcSEcCtD
Rimonabant—Rash—Prednisolone—ulcerative colitis	0.000243	0.0011	CcSEcCtD
Rimonabant—Dermatitis—Prednisolone—ulcerative colitis	0.000243	0.0011	CcSEcCtD
Rimonabant—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000242	0.0011	CcSEcCtD
Rimonabant—Fatigue—Prednisone—ulcerative colitis	0.000242	0.00109	CcSEcCtD
Rimonabant—Headache—Prednisolone—ulcerative colitis	0.000242	0.00109	CcSEcCtD
Rimonabant—Vomiting—Hydrocortisone—ulcerative colitis	0.000239	0.00108	CcSEcCtD
Rimonabant—Rash—Hydrocortisone—ulcerative colitis	0.000237	0.00107	CcSEcCtD
Rimonabant—Dermatitis—Hydrocortisone—ulcerative colitis	0.000237	0.00107	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000237	0.00249	CbGpPWpGaD
Rimonabant—Headache—Hydrocortisone—ulcerative colitis	0.000236	0.00107	CcSEcCtD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000236	0.00247	CbGpPWpGaD
Rimonabant—Dizziness—Triamcinolone—ulcerative colitis	0.000235	0.00106	CcSEcCtD
Rimonabant—Dizziness—Methylprednisolone—ulcerative colitis	0.000234	0.00106	CcSEcCtD
Rimonabant—Asthenia—Betamethasone—ulcerative colitis	0.000231	0.00104	CcSEcCtD
Rimonabant—Asthenia—Dexamethasone—ulcerative colitis	0.000231	0.00104	CcSEcCtD
Rimonabant—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000229	0.00104	CcSEcCtD
Rimonabant—Nausea—Prednisolone—ulcerative colitis	0.000229	0.00104	CcSEcCtD
Rimonabant—Pruritus—Betamethasone—ulcerative colitis	0.000228	0.00103	CcSEcCtD
Rimonabant—Pruritus—Dexamethasone—ulcerative colitis	0.000228	0.00103	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL20—ulcerative colitis	0.000227	0.00239	CbGpPWpGaD
Rimonabant—Vomiting—Triamcinolone—ulcerative colitis	0.000225	0.00102	CcSEcCtD
Rimonabant—Vomiting—Methylprednisolone—ulcerative colitis	0.000225	0.00102	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.000225	0.00236	CbGpPWpGaD
Rimonabant—Nausea—Hydrocortisone—ulcerative colitis	0.000224	0.00101	CcSEcCtD
Rimonabant—Rash—Triamcinolone—ulcerative colitis	0.000224	0.00101	CcSEcCtD
Rimonabant—Dermatitis—Triamcinolone—ulcerative colitis	0.000223	0.00101	CcSEcCtD
Rimonabant—Rash—Methylprednisolone—ulcerative colitis	0.000223	0.00101	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000223	0.00234	CbGpPWpGaD
Rimonabant—Dermatitis—Methylprednisolone—ulcerative colitis	0.000223	0.00101	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.000223	0.00234	CbGpPWpGaD
Rimonabant—Headache—Triamcinolone—ulcerative colitis	0.000222	0.00101	CcSEcCtD
Rimonabant—Headache—Methylprednisolone—ulcerative colitis	0.000222	0.001	CcSEcCtD
Rimonabant—Abdominal pain—Prednisone—ulcerative colitis	0.000222	0.001	CcSEcCtD
Rimonabant—Diarrhoea—Betamethasone—ulcerative colitis	0.00022	0.000996	CcSEcCtD
Rimonabant—Diarrhoea—Dexamethasone—ulcerative colitis	0.00022	0.000996	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—ADRB2—ulcerative colitis	0.000215	0.00226	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GNA12—ulcerative colitis	0.000214	0.00224	CbGpPWpGaD
Rimonabant—Dizziness—Betamethasone—ulcerative colitis	0.000213	0.000963	CcSEcCtD
Rimonabant—Dizziness—Dexamethasone—ulcerative colitis	0.000213	0.000963	CcSEcCtD
Rimonabant—Nausea—Triamcinolone—ulcerative colitis	0.000211	0.000953	CcSEcCtD
Rimonabant—Nausea—Methylprednisolone—ulcerative colitis	0.00021	0.000951	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000209	0.00219	CbGpPWpGaD
Rimonabant—Vomiting—Dexamethasone—ulcerative colitis	0.000205	0.000926	CcSEcCtD
Rimonabant—Vomiting—Betamethasone—ulcerative colitis	0.000205	0.000926	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000204	0.00214	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—GHRL—ulcerative colitis	0.000204	0.00214	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCR1—ulcerative colitis	0.000203	0.00213	CbGpPWpGaD
Rimonabant—Rash—Betamethasone—ulcerative colitis	0.000203	0.000918	CcSEcCtD
Rimonabant—Rash—Dexamethasone—ulcerative colitis	0.000203	0.000918	CcSEcCtD
Rimonabant—Dermatitis—Betamethasone—ulcerative colitis	0.000203	0.000917	CcSEcCtD
Rimonabant—Dermatitis—Dexamethasone—ulcerative colitis	0.000203	0.000917	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CXCR2—ulcerative colitis	0.000203	0.00213	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCL8—ulcerative colitis	0.000202	0.00213	CbGpPWpGaD
Rimonabant—Headache—Betamethasone—ulcerative colitis	0.000202	0.000912	CcSEcCtD
Rimonabant—Headache—Dexamethasone—ulcerative colitis	0.000202	0.000912	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000201	0.00211	CbGpPWpGaD
Rimonabant—Asthenia—Prednisone—ulcerative colitis	0.000201	0.00091	CcSEcCtD
Rimonabant—Pruritus—Prednisone—ulcerative colitis	0.000198	0.000897	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CALM3—ulcerative colitis	0.000197	0.00207	CbGpPWpGaD
Rimonabant—Diarrhoea—Prednisone—ulcerative colitis	0.000192	0.000867	CcSEcCtD
Rimonabant—Nausea—Betamethasone—ulcerative colitis	0.000191	0.000865	CcSEcCtD
Rimonabant—Nausea—Dexamethasone—ulcerative colitis	0.000191	0.000865	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCR6—ulcerative colitis	0.00019	0.002	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000186	0.00195	CbGpPWpGaD
Rimonabant—Dizziness—Prednisone—ulcerative colitis	0.000185	0.000838	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—ADCY5—ulcerative colitis	0.000183	0.00192	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000182	0.00191	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAML2—ulcerative colitis	0.000181	0.0019	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL20—ulcerative colitis	0.000178	0.00187	CbGpPWpGaD
Rimonabant—Vomiting—Prednisone—ulcerative colitis	0.000178	0.000806	CcSEcCtD
Rimonabant—Rash—Prednisone—ulcerative colitis	0.000177	0.000799	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—ulcerative colitis	0.000177	0.000799	CcSEcCtD
Rimonabant—Headache—Prednisone—ulcerative colitis	0.000176	0.000794	CcSEcCtD
Rimonabant—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000173	0.00182	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000172	0.00181	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.000169	0.00177	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTGER4—ulcerative colitis	0.000168	0.00176	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GNA12—ulcerative colitis	0.000168	0.00176	CbGpPWpGaD
Rimonabant—Nausea—Prednisone—ulcerative colitis	0.000166	0.000753	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CXCR2—ulcerative colitis	0.000159	0.00167	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000159	0.00167	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000158	0.00166	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GHRL—ulcerative colitis	0.000154	0.00161	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000151	0.00158	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCR6—ulcerative colitis	0.000149	0.00157	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CALM3—ulcerative colitis	0.000149	0.00156	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	0.000148	0.00155	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RIPK2—ulcerative colitis	0.000146	0.00154	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000146	0.00154	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000144	0.00151	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.000143	0.0015	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	0.000142	0.00149	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAML2—ulcerative colitis	0.000142	0.00149	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	0.000138	0.00145	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTGER4—ulcerative colitis	0.000132	0.00138	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000129	0.00135	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000128	0.00135	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000128	0.00134	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADRB2—ulcerative colitis	0.000127	0.00133	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—JAK2—ulcerative colitis	0.000125	0.00132	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	0.000125	0.00131	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GHRL—ulcerative colitis	0.00012	0.00126	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.00012	0.00125	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CALM3—ulcerative colitis	0.000117	0.00122	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000115	0.00121	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000114	0.0012	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—JAK2—ulcerative colitis	0.000114	0.0012	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—IL2—ulcerative colitis	0.000109	0.00115	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADCY5—ulcerative colitis	0.000108	0.00113	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL8—ulcerative colitis	0.000104	0.00109	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADRB2—ulcerative colitis	9.97e-05	0.00105	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	9.96e-05	0.00105	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—ulcerative colitis	9.93e-05	0.00104	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—JAK2—ulcerative colitis	9.84e-05	0.00103	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	9.66e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	9.3e-05	0.000976	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	9.3e-05	0.000976	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL8—ulcerative colitis	8.98e-05	0.000943	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—JAK2—ulcerative colitis	8.93e-05	0.000938	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—ulcerative colitis	8.58e-05	0.000901	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADCY5—ulcerative colitis	8.46e-05	0.000889	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL8—ulcerative colitis	8.15e-05	0.000856	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—ulcerative colitis	7.79e-05	0.000818	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—JAK2—ulcerative colitis	6.72e-05	0.000706	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RELA—ulcerative colitis	6.51e-05	0.000684	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—ulcerative colitis	6.14e-05	0.000644	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CHP1—ulcerative colitis	6.05e-05	0.000635	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CHP1—ulcerative colitis	6e-05	0.00063	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—ulcerative colitis	5.87e-05	0.000616	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—ulcerative colitis	5.84e-05	0.000613	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.62e-05	0.00059	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—ulcerative colitis	5.55e-05	0.000583	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NFKB1—ulcerative colitis	5.49e-05	0.000577	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—JAK2—ulcerative colitis	5.28e-05	0.000554	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DLD—ulcerative colitis	5.22e-05	0.000549	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DLD—ulcerative colitis	5.18e-05	0.000544	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CHP1—ulcerative colitis	5.13e-05	0.000538	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RELA—ulcerative colitis	5.11e-05	0.000537	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—ulcerative colitis	4.94e-05	0.000518	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—ulcerative colitis	4.82e-05	0.000506	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.8e-05	0.000504	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—ulcerative colitis	4.6e-05	0.000483	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—ulcerative colitis	4.58e-05	0.000481	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFB1—ulcerative colitis	4.57e-05	0.00048	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DLD—ulcerative colitis	4.43e-05	0.000465	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—ulcerative colitis	4.36e-05	0.000457	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NFKB1—ulcerative colitis	4.31e-05	0.000452	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.96e-05	0.000415	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—ulcerative colitis	3.87e-05	0.000407	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—ulcerative colitis	3.77e-05	0.000395	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFB1—ulcerative colitis	3.59e-05	0.000377	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—ulcerative colitis	3.45e-05	0.000362	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DLD—ulcerative colitis	3.42e-05	0.000359	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—ulcerative colitis	2.96e-05	0.00031	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.74e-05	0.000288	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—ulcerative colitis	2.71e-05	0.000284	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS1—ulcerative colitis	2.53e-05	0.000265	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS1—ulcerative colitis	2.5e-05	0.000263	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.46e-05	0.000259	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.34e-05	0.000246	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CALM3—ulcerative colitis	2.27e-05	0.000239	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CALM3—ulcerative colitis	2.25e-05	0.000237	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.15e-05	0.000226	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS1—ulcerative colitis	2.14e-05	0.000225	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.1e-05	0.000221	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CALM3—ulcerative colitis	1.93e-05	0.000202	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.84e-05	0.000193	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—ulcerative colitis	1.77e-05	0.000186	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.75e-05	0.000184	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.65e-05	0.000173	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADCY5—ulcerative colitis	1.65e-05	0.000173	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.64e-05	0.000172	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—ulcerative colitis	1.5e-05	0.000157	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.49e-05	0.000156	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADCY5—ulcerative colitis	1.4e-05	0.000147	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARG—ulcerative colitis	1.23e-05	0.000129	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARG—ulcerative colitis	1.22e-05	0.000128	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.16e-05	0.000121	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—ulcerative colitis	1.11e-05	0.000116	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—ulcerative colitis	1.1e-05	0.000115	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.08e-05	0.000113	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.04e-05	0.000109	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—ulcerative colitis	9.68e-06	0.000102	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—ulcerative colitis	9.6e-06	0.000101	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—ulcerative colitis	9.37e-06	9.84e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—ulcerative colitis	8.2e-06	8.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARG—ulcerative colitis	8.04e-06	8.45e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—ulcerative colitis	7.23e-06	7.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—ulcerative colitis	6.33e-06	6.64e-05	CbGpPWpGaD
